Relationship between intention of novel influenza A (H1N1) vaccination and vaccination coverage rate

Vaccine

Volumn 29, Issue 2, 2010, Pages 161-165

  Kwon, Yunhyung ^a   Cho, Hee Yeon ^a   Lee, Yeon Kyeng ^a   Bae, Geun Ryang ^a   Lee, Sok Goo ^b  

^a Korea Centers for Disease Control and Prevention   (South Korea)

^b Chungnam National University   (South Korea)

Author keywords

Intention of vaccination; Novel influenza A (H1N1); Vaccination coverage rate

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CHILD; CONTROLLED STUDY; DRUG SAFETY; FEMALE; GENDER; HEALTH SURVEY; HUMAN; INFLUENZA A (H1N1); INFLUENZA VACCINATION; KOREA; MAJOR CLINICAL STUDY; MALE; PANDEMIC INFLUENZA; POPULATION DISTRIBUTION; PRIORITY JOURNAL; SAMPLE SIZE; SCHOOL CHILD; VACCINE PRODUCTION;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; REPUBLIC OF KOREA; VACCINATION; YOUNG ADULT;

EID: 78649696972     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.10.063     Document Type: Article

References (13)

1. WHO. World now at the start of 2009 influenza pandemic. Available from: http://www.who.int/mediacentre/news/statements/2009/h1n1_pandemic_phase6_20090611/en/print.html.
2. Cho H.Y., Kim C.H., Go U.Y., Lee H.J. Immunization decision-making in the Republic of Korea: the structure and functioning of the Korea Advisory Committee on Immunization Practices. Vaccine 2010, 28:A91-A95.
3. Khazeni N., Hutton D.W., Garber A.M., Hupert N., Owens D.K. Effectiveness and cost-effectiveness of vaccination against pandemic influenza (H1N1) 2009. Ann Intern Med 2009.
4. Eastwood K., Durrheim D.N., Jones A., Butler M. Acceptance of pandemic (H1N1) 2009 influenza vaccination by the Australian public. Med J Aust 2010, 192(1):33-36.
5. Maurer J., Harris K.M., Parker A., Lurie N. Does receipt of seasonal influenza vaccine predict intention to receive novel H1N1 vaccine: evidence from a nationally representative survey of U.S. adults. Vaccine 2009, 27:5732-5734.
6. Centers for Disease Control and Prevention (CDC) Interim results: state-specific influenza A (1N1) 2009 monovalent vaccination coverage-United States, October 2009-January. MMWR 2010, 59(12):363-368.
7. Van den Akker I.L., van Delden J.J.M., Verheij T.J.M., van Essen G.A., van der Sande M.A.B., Hulscher M.E., et al. Which determinants should be targeted to increase vaccination uptake among health workers in nursing homes?. Vaccine 2009, 27:4724-4730.
8. Centers for Disease Control and Prevention (CDC) Intent to Receive Influenza A (H1N1) 2009 Monovalent and Seasonal Influenza Vaccines - two counties, North Carolina, August 2009. MMWR 2009, 58(25):1401-1405.
9. Quinn S.C., Thomas T., Kumar S. The anthrax vaccine and research: reactions from postal workers and public health professionals. Biosecur Bioterror 2008, 6(4):321-333.
10. Quinn S.C., Kumar S., Freimuth V.S., Kidwell K., Musa D. Public willingness to take a vaccine or drug under emergency use authorization during the 2009 H1N1 pandemic. Biosecur Bioterror 2009, 7(3):275-290.
11. Choi W.S., Kim W.J., Jung H.J. The evaluation of policies on 2009 influenza pandemic in Korea. J Prev Med Public Health 2010, 43(2):105-108.
12. Mylius S.D., Hagenaars T.J., Lugner A.K., Wallinga J. Optimal allocation of pandemic influenza vaccine depends on age, risk and timing. Vaccine 2008, 26:3742-3749.
13. Lau J.T.F., Yeung N.C.Y., Choi K.C., Cheng M.Y.M., Tsui H.Y., Griffiths S. Acceptability of A/H1N1 vaccination during in Hong Kong: population based cross sectional survey. BMJ 2009, 339:b4164.